Literature DB >> 2261710

EPM-ROM Scale: an evaluative instrument to be used in rheumatoid arthritis trials.

M B Ferraz1, L M Oliveira, P M Araujo, E Atra, S D Walter.   

Abstract

Different tools are available for the measurement of functional status; however, only a few of them are based on the evaluation of the joint range of motion (ROM). This study is aimed at the design and evaluation of the measurement properties of a ROM scale to be used as an evaluative instrument in rheumatoid arthritis (RA) trials. The EPM-ROM Scale evaluates 10 distinct movements of the small and large joints. The score of each joint varies from 0 (full movement) to 3 (severe limitation) and the cut-off degrees of motion are, in general, based on the lack of ability to perform some determined activities of daily living. The test-retest characteristic of the scale was assessed by administering the scale twice, 5 days apart, to 35 RA patients. The product moment correlation was 0.775 (P less than 0.001). The cross-sectional construct validity of the scale was assessed by the concomitant scoring of the EPM-ROM Scale and the functional ability dimension of the Health Assessment Questionnaire (a reliable, valid and responsive instrument) in these patients. The product moment correlation was 0.518 (P less than 0.001). The evaluation of its longitudinal construct validity and responsiveness are now in progress.

Entities:  

Mesh:

Year:  1990        PMID: 2261710

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  8 in total

Review 1.  Impairment measures in rheumatic disorders for rehabilitation medicine and allied health care: a systematic review.

Authors:  Raymond A H M Swinkels; Lex M Bouter; Rob A B Oostendorp; Cornelia H M van den Ende
Journal:  Rheumatol Int       Date:  2005-06-24       Impact factor: 2.631

2.  Comparison of high and low intensity training in well controlled rheumatoid arthritis. Results of a randomised clinical trial.

Authors:  C H van den Ende; J M Hazes; S le Cessie; W J Mulder; D G Belfor; F C Breedveld; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  1996-11       Impact factor: 19.103

3.  Effect of intensive exercise on patients with active rheumatoid arthritis: a randomised clinical trial.

Authors:  C H van den Ende; F C Breedveld; S le Cessie; B A Dijkmans; A W de Mug; J M Hazes
Journal:  Ann Rheum Dis       Date:  2000-08       Impact factor: 19.103

4.  The rheumatoid arthritis articular damage score: first steps in developing a clinical index of long term damage in RA.

Authors:  T R Zijlstra; H J Bernelot Moens; M A S Bukhari
Journal:  Ann Rheum Dis       Date:  2002-01       Impact factor: 19.103

5.  Is articular pain in rheumatoid arthritis correlated with ultrasound power Doppler findings?

Authors:  Daniele Freitas Pereira; Marwin Gutierrez; Ana Leticia Pirozzi de Buosi; Fernando Bernardes Maia Diniz Ferreira; Antonella Draghessi; Walter Grassi; Jamil Natour; Rita Nely Vilar Furtado
Journal:  Clin Rheumatol       Date:  2015-05-09       Impact factor: 2.980

6.  Pain and joint mobility explain individual subdimensions of the health assessment questionnaire (HAQ) disability index in patients with rheumatoid arthritis.

Authors:  A Häkkinen; H Kautiainen; P Hannonen; J Ylinen; M Arkela-Kautiainen; T Sokka
Journal:  Ann Rheum Dis       Date:  2004-05-06       Impact factor: 19.103

7.  Functional disability associated with disease and quality-of-life parameters in Chinese patients with rheumatoid arthritis.

Authors:  Juan Ji; Lijuan Zhang; Qiuxiang Zhang; Rulan Yin; Ting Fu; Liren Li; Zhifeng Gu
Journal:  Health Qual Life Outcomes       Date:  2017-05-02       Impact factor: 3.186

8.  Is painless synovitis different from painful synovitis? A controlled, ultrasound, radiographic, clinical trial.

Authors:  Daniele Freitas Pereira; Jamil Natour; Ana Leticia Pirozzi de Buosi; Fernando Bernardes Maia Diniz Ferreira; Artur da Rocha Corrêa Fernandes; Rita Nely Vilar Furtado
Journal:  Clinics (Sao Paulo)       Date:  2014-02       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.